I ditto your thought here DWH. In 2013 the bad news was extremely closely held at RVX. This being a pivotal trial I would guess that there are not to many people that know and those that do must keep it very close to their chest.

As far as Hepalink goes, if this news reflects the triple play my mid case valuation for RVX would more than warrant a doubling of Hepalinks market cap. There may even be good reason for Hepalinks stock to be halted for a time until our news comes out as well if the news is great. If the news is not good Hepa may take a bit of a hit but not devastatingly so like RVX could.

All IMO, dyodd.

tada